// App-Quantinova.ai

PO0060 : DOACs CHALLENGING CHOICE IN CONCOMITANT JUGULAR VEIN AND HEPATIC ARTERY THROMBOSIS IN A BREAST CANCER PATIENT WITH LIVER ARTERIAL INFUSION CHEMOTHERAPY (LAIC): A UNIQUE CLINICAL CASE.

Researchers

Presenter

  • A. Fioretti

Principal Investigators

  • M. Porcelli

  • S. Oliva

Medical Centers

  • Interventional and Medical Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, taly, Bari, Puglia, Italy

  • Cardiology and Intensive Care Unit, Ospedale SS. Annunziata, Taranto, Italy, Bari, Puglia, Italy

  • Interventional and Medical Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, taly, Bari, Puglia, Italy

  • Interventional and Medical Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, taly, Bari, Puglia, Italy

  • Cardiology and Intensive Care Unit, Ospedale SS. Annunziata, Taranto, Italy, Bari, Puglia, Italy

  • Interventional and Medical Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, taly, Bari, Puglia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Deep vein thrombosis

  • Breast cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Proliferation marker protein Ki-67

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • aspirin + clopidogrel

  • Bevacizumab

  • Trastuzumab

  • Clopidogrel bisulfate

  • Enoxaparin

  • Enoxaparin sodium

  • Parnaparin

  • Edoxaban

  • Aspirin

  • Albyl-E

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved